Últimas noticias sobre Imperial Ptrl (NASDAQ:IMPP) Bolsa

Imperial Ptrl

Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil and jet fuel, as well as edible oils and chemicals.

Imperial Petroleum Inc

Imperial Petroleum Inc. - 8.75% Series A Cumulative Redeemable Perpetual Preferred Shares

Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-04-16. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Abbott Laboratories will report an earnings per share (EPS) of $1.07.
The market awaits Abbott Laboratories's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Overview of Past Earnings</h3>
During the last quarter, the company reported an EPS missed by $0.00, leading to a 4.62% increase in the share price on the subsequent day.
Here's a look at Abbott Laboratories's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.34</td>
<td>1.20</td>
<td>1.10</td>
<td>0.95</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.34</td>
<td>1.21</td>
<td>1.14</td>
<td>0.98</td>
</tr>
<tr>
<td>Price Change %</td>
<td>5.0%</td>
<td>0.0%</td>
<td>2.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1744725676_0.png" alt="eps graph" />
<h3>Tracking Abbott Laboratories's Stock Performance</h3>
Shares of Abbott Laboratories were trading at $127.37 as of April 14. Over the last 52-week period, shares are up 20.51%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Analysts' Perspectives on Abbott Laboratories</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Abbott Laboratories.
Abbott Laboratories has received a total of 9 ratings from analysts, with the consensus rating as Buy. With an average one-year price target of $145.67, the consensus suggests a potential 14.37% upside.
<h3>Comparing Ratings with Competitors</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Intuitive Surgical, Boston Scientific and Stryker, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Intuitive Surgical, with an average 1-year price target of $662.75, suggesting a potential 420.33% upside.</li>
<li>Analysts currently favor an Buy trajectory for Boston Scientific, with an average 1-year price target of $119.0, suggesting a potential 6.57% downside.</li>
<li>Analysts currently favor an Buy trajectory for Stryker, with an average 1-year price target of $437.0, suggesting a potential 243.09% upside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
The peer analysis summary provides a snapshot of key metrics for Intuitive Surgical, Boston Scientific and Stryker, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Abbott Laboratories</td>
<td>Buy</td>
<td>7.16%</td>
<td>$6.03B</td>
<td>21.10%</td>
</tr>
<tr>
<td>Intuitive Surgical</td>
<td>Outperform</td>
<td>25.16%</td>
<td>$1.64B</td>
<td>4.28%</td>
</tr>
<tr>
<td>Boston Scientific</td>
<td>Buy</td>
<td>22.44%</td>
<td>$3.10B</td>
<td>2.66%</td>
</tr>
<tr>
<td>Stryker</td>
<td>Buy</td>
<td>10.68%</td>
<td>$4.17B</td>
<td>2.68%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Abbott Laboratories ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.
<h3>Get to Know Abbott Laboratories Better</h3>
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
<h3>Abbott Laboratories's Financial Performance</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Abbott Laboratories's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 7.16%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Abbott Laboratories's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 84.1%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Abbott Laboratories's ROE excels beyond industry benchmarks, reaching 21.1%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Abbott Laboratories's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 11.85%, the company showcases efficient use of assets and strong financial health.
Debt Management: Abbott Laboratories's debt-to-equity ratio is below the industry average. With a ratio of 0.32, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/ABT/earnings">To track all earnings releases for Abbott Laboratories visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Abbott Laboratories's Earnings Outlook

In the last three months, 12 analysts have published ratings on ZoomInfo Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NASDAQ">ZI</a>), offering a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $11.75, a high estimate of $15.00, and a low estimate of $8.00. Marking an increase of 0.86%, the current average surpasses the previous average price target of $11.65. 
<img src="https://www.benzinga.com/files/images/story/2025/1744725669_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive ZoomInfo Technologies. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Siti Panigrahi &#x7C;Mizuho &#x7C;Lowers &#x7C;Neutral &#x7C; $9.00&#x7C;$11.00 &#x7C; 
&#x7C;Gil Luria &#x7C;DA Davidson &#x7C;Lowers &#x7C;Neutral &#x7C; $8.00&#x7C;$13.00 &#x7C; 
&#x7C; Allan Verkhovski &#x7C;Scotiabank &#x7C;Raises &#x7C;Sector Perform &#x7C; $11.00&#x7C;$10.30 &#x7C; 
&#x7C;David Hynes &#x7C;Canaccord Genuity &#x7C;Raises &#x7C;Buy &#x7C; $15.00&#x7C;$14.00 &#x7C; 
&#x7C;Elizabeth Porter &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Equal-Weight &#x7C; $13.00&#x7C;$11.00 &#x7C; 
&#x7C;Michael Turrin &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $12.00&#x7C;$11.00 &#x7C; 
&#x7C;Parker Lane &#x7C;Stifel &#x7C;Raises &#x7C;Buy &#x7C; $14.00&#x7C;$13.00 &#x7C; 
&#x7C;Joshua Reilly &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $15.00&#x7C;$15.00 &#x7C; 
&#x7C;Brent Bracelin &#x7C;Piper Sandler &#x7C;Raises &#x7C;Neutral &#x7C; $11.00&#x7C;$10.00 &#x7C; 
&#x7C;Raimo Lenschow &#x7C;Barclays &#x7C;Raises &#x7C;Equal-Weight &#x7C; $13.00&#x7C;$11.00 &#x7C; 
&#x7C;Tyler Radke &#x7C;Citigroup &#x7C;Raises &#x7C;Sell &#x7C; $9.00&#x7C;$8.50 &#x7C; 
&#x7C;Raimo Lenschow &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $11.00&#x7C;$12.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to ZoomInfo Technologies. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of ZoomInfo Technologies compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of ZoomInfo Technologies's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of ZoomInfo Technologies's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ZI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on ZoomInfo Technologies analyst ratings.</a>
<h2>Get to Know ZoomInfo Technologies Better</h2>
ZoomInfo Technologies Inc provides a go-to-market intelligence platform for sales and marketing teams. Its cloud-based go-to-market data and insights platform deliver comprehensive and high-quality intelligence and analytics to provide sales and marketing professionals with accurate information and insights on the organizations and professionals. Nearly all of its revenue is derived from the United States.
<h3>ZoomInfo Technologies: A Financial Overview</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Negative Revenue Trend: Examining ZoomInfo Technologies's financials over 3M reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -2.31% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Communication Services sector.
Net Margin: ZoomInfo Technologies's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.72% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 0.87%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): ZoomInfo Technologies's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.23%, the company may face hurdles in achieving optimal financial returns.
Debt Management: ZoomInfo Technologies's debt-to-equity ratio stands notably higher than the industry average, reaching 0.82. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>How Are Analyst Ratings Determined?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

What Analysts Are Saying About ZoomInfo Technologies Stock

U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-04-16. Here's a quick overview of what investors should know before the release.
Analysts are estimating that U.S. Bancorp will report an earnings per share (EPS) of $0.98.
U.S. Bancorp bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Performance in Previous Earnings</h3>
Last quarter the company beat EPS by $0.02, which was followed by a 0.69% increase in the share price the next day.
Here's a look at U.S. Bancorp's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.05</td>
<td>0.99</td>
<td>0.94</td>
<td>0.88</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.07</td>
<td>1.03</td>
<td>0.98</td>
<td>0.90</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>2.0%</td>
<td>-2.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1744725665_0.png" alt="eps graph" />
<h3>Market Performance of U.S. Bancorp's Stock</h3>
Shares of U.S. Bancorp were trading at $38.2 as of April 14. Over the last 52-week period, shares are down 1.44%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/USB/earnings">To track all earnings releases for U.S. Bancorp visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Peek at U.S. Bancorp's Future Earnings

<ul>
<li>On April 8 United Wholesale Mortgage announced a partnership with Google AI</li>
<li>The mortgage lender plans to use Google Cloud services to automate underwriting and streamline document handling</li>
<li>According to UWM, the partnership has already allowed them to more than double their output</li>
</ul>
United Wholesale Mortgage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UWMC#NYSE">UWMC</a>), the top mortgage lender in the country, <a href="https://www.businesswire.com/news/home/20250408796561/en/Google-Cloud-and-United-Wholesale-Mortgage-Announce-Industry-Transformative-Partnership-to-Modernize-the-Mortgage-Lending-Process">announced</a> an AI partnership with Google Cloud on April 8. The goal of the partnership, according to the two companies, is to bring modernization to the mortgage industry.
Using Google Cloud's AI and machine learning tools, UWM hopes to increase automation in underwriting, streamline document handling, and improve client services with AI-chat tools. UWM is now among the first companies to use Google Gemini Flash 1.5 to automate its underwriting tasks.
Don't Miss:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>
According to UWM, it has already increased output of underwriting loans from six a day to 14, more than doubling its productivity. This is while the industry average remains at just three loans per day.
Jason Bressler, UWM's chief technology officer, told <a href="https://www.housingwire.com/articles/uwm-and-google-announce-ai-partnership/">Housingwire</a>, "We decided to really take the plunge into everything AI probably about two years ago, and we've been working with Google on their different extraction modeling, their platform, their data lakes. We've got a pretty large partnership with Google at this point."
The two companies are also exploring other ways to expand the partnership, according UWM. UWM is looking to utilize Google Cloud Infrastructure to improve scalability and security, which will lead to a more seamless and expedited mortgage experience. It will also plans to use Google Cloud to enhance its data-driven insights, in an effort to give more personalized loan recommendations and identifications.&nbsp;
Trending: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
Oliver Parker, Google Cloud's vice president of AI, told Housingwire the partnership is a great example of how AI can be used in technical processes like mortgage lending. "One side is helping on the back office side, the origination side and providing brokers more data quicker. The other is how you think about things on the front side. With a lot of the automation, you start to think about voice on the front end. You think about a full customer journey. Jason and I have often talked about how much more we could be doing here…that we can do when you start thinking about experience for a home buyer as well as what you could truly do for brokers and putting them in a position to be the most successful."
And Google has no plans to stop here. It's also begun working on bringing its AI services to capital markets and insurance companies.
See Also: Invest in the future of digital engagement: <a href="https://www.benzinga.com/money/vatom-adv">Own a piece of the $100 billion Metaverse for just $500</a>.
"There is sort of a full scale set of capabilities that we are now beginning to see are incredibly valuable and starting to get what I would call sort of traction at scale. Twelve months ago, you would see pockets of what I would call experimentation. You see proof of concepts, and they would light up certain things…but we're now moving more towards these systems starting to scale and actually being applied, especially externally," Parker told Housingwire.&nbsp;
As for UWM, Bressler says that the benefits of the partnership will be immediate for its broker partners. "They're going to see a lot of clarity and very quick understanding of what they're submitting, what it means, what their income is, their assets, their documents," he told Housingwire. "And they're going to see an incredibly fast kind of understanding of the products that they qualify for, that their borrower qualifies for. They're going to be saving homeowners thousands of dollars a year."
Read Next:
<ul>
<li>With shares starting at $1.52, <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">this could be your chance to invest in the future of healthcare</a>.</li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>

News

UWMC

United Wholesale Mortgage Announces Partnership With Google AI, Says It's 'All In' On AI

Whales with a lot of money to spend have taken a noticeably bullish stance on AbbVie.
Looking at options history for AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 62% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $316,131 and 5, calls, for a total amount of $572,360.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $80.0 to $200.0 for AbbVie over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for AbbVie's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of AbbVie's whale activity within a strike price range from $80.0 to $200.0 in the last 30 days. 
<h3>AbbVie Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744725660_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$100.0</td>
<td>$98.05</td>
<td>$100.0</td>
<td>$80.00</td>
<td>$340.0K</td>
<td>0</td>
<td align="right">34</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$1.69</td>
<td>$1.68</td>
<td>$1.68</td>
<td>$150.00</td>
<td>$151.6K</td>
<td>3.6K</td>
<td align="right">1</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.34</td>
<td>$2.18</td>
<td>$2.33</td>
<td>$155.00</td>
<td>$108.3K</td>
<td>2.3K</td>
<td align="right">0</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$10.55</td>
<td>$10.3</td>
<td>$10.3</td>
<td>$175.00</td>
<td>$103.0K</td>
<td>3.0K</td>
<td align="right">68</td>
</tr>
<tr>
<td>ABBV</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$28.25</td>
<td>$27.5</td>
<td>$28.08</td>
<td>$200.00</td>
<td>$56.1K</td>
<td>998</td>
<td align="right">20</td>
</tr>
</tbody>
</table>

<h3>About AbbVie</h3>
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
<h3>Current Position of AbbVie</h3>
<ul>
<li>Currently trading with a volume of 559,562, the ABBV's price is up by 1.11%, now at $179.44. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 10 days.</li>
</ul>
<h3>What The Experts Say On AbbVie</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $217.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on AbbVie, which currently sits at a price target of $241. 
&#x2A; In a cautious move, an analyst from Goldman Sachs downgraded its rating to Neutral, setting a price target of $194. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for AbbVie, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

ABBV

AbbVie Options Trading: A Deep Dive into Market Sentiment

In the latest quarter, 6 analysts provided ratings for BXP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXP#NYSE">BXP</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $84.17, a high estimate of $100.00, and a low estimate of $78.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 9.88%. 
<img src="https://www.benzinga.com/files/images/story/2025/1744725661_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive BXP is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Alexander Goldfarb &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Overweight &#x7C; $85.00&#x7C;$100.00 &#x7C; 
&#x7C;Peter Abramowitz &#x7C;Jefferies &#x7C;Announces &#x7C;Buy &#x7C; $78.00&#x7C;- &#x7C; 
&#x7C;Anthony Powell &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $79.00&#x7C;$89.00 &#x7C; 
&#x7C;Nicholas Yulico &#x7C;Scotiabank &#x7C;Lowers &#x7C;Sector Perform &#x7C; $83.00&#x7C;$85.00 &#x7C; 
&#x7C;Blaine Heck &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Overweight &#x7C; $80.00&#x7C;$88.00 &#x7C; 
&#x7C;Alexander Goldfarb &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Overweight &#x7C; $100.00&#x7C;$105.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to BXP. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of BXP compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of BXP's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into BXP's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BXP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on BXP analyst ratings.</a>
<h2>Discovering BXP: A Closer Look</h2>
BXP Inc. owns over 180 properties consisting of approximately 53 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.
<h3>BXP's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: BXP's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 3.58%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: BXP's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -26.66%, the company may face hurdles in effective cost management.
Return on Equity (ROE): BXP's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -4.1%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): BXP's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.87%, the company may face hurdles in achieving optimal financial performance.
Debt Management: BXP's debt-to-equity ratio is notably higher than the industry average. With a ratio of 3.14, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On BXP Through 6 Analysts

Investors with a lot of money to spend have taken a bearish stance on NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NVDA, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 101 uncommon options trades for NVIDIA.
This isn't normal.
The overall sentiment of these big-money traders is split between 39% bullish and 47%, bearish.
Out of all of the special options we uncovered, 16 are puts, for a total amount of $830,701, and 85 are calls, for a total amount of $4,203,274.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $92.0 to $140.0 for NVIDIA during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in NVIDIA's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to NVIDIA's substantial trades, within a strike price spectrum from $92.0 to $140.0 over the preceding 30 days.
<h3>NVIDIA Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744725655_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$2.33</td>
<td>$2.32</td>
<td>$2.32</td>
<td>$112.00</td>
<td>$106.6K</td>
<td>18.9K</td>
<td>23.1K</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$6.35</td>
<td>$6.3</td>
<td>$6.35</td>
<td>$122.00</td>
<td>$99.6K</td>
<td>6.1K</td>
<td>221</td>
</tr>
<tr>
<td>NVDA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$6.55</td>
<td>$6.5</td>
<td>$6.55</td>
<td>$92.00</td>
<td>$96.9K</td>
<td>12.3K</td>
<td>51</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$2.31</td>
<td>$2.3</td>
<td>$2.3</td>
<td>$112.00</td>
<td>$71.6K</td>
<td>18.9K</td>
<td>35.9K</td>
</tr>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$1.06</td>
<td>$1.04</td>
<td>$1.04</td>
<td>$115.00</td>
<td>$68.1K</td>
<td>148.6K</td>
<td>20.9K</td>
</tr>
</tbody>
</table>

<h3>About NVIDIA</h3>
Nvidia Corp is an upfront developer of graphics processing unit and a full-stack computing infrastructure company with data-center-scale offerings that are reshaping industry. Traditionally, GPU were used to enhanvce experience,now Nvidia offers AI GPUs, and also a software platform, Cuda, used for AI model development and training. The company is also expanding its data center networking solutions, helping to tie GPUs together to handle complex workloads. such as AI, model training and inference, data analytics, scientific computing, and 3D graphics, with vertical-specific optimizations to address industries ranging from healthcare and telecom to automotive and manufacturing.
<h3>Present Market Standing of NVIDIA</h3>
<ul>
<li>With a volume of 25,910,660, the price of NVDA is up 0.9% at $111.7. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 36 days.</li>
</ul>
<h3>Expert Opinions on NVIDIA</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $159.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from TD Cowen has decided to maintain their Buy rating on NVIDIA, which currently sits at a price target of $140. 
&#x2A; An analyst from DA Davidson persists with their Neutral rating on NVIDIA, maintaining a target price of $125. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $200. 
&#x2A; An analyst from Susquehanna has decided to maintain their Positive rating on NVIDIA, which currently sits at a price target of $180. 
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on NVIDIA with a target price of $150. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest NVIDIA options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

NVDA

This Is What Whales Are Betting On NVIDIA

Progressive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-04-16. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Progressive will report an earnings per share (EPS) of $4.79.
Investors in Progressive are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Past Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $0.52, leading to a 1.14% increase in the share price on the subsequent day.
Here's a look at Progressive's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>3.56</td>
<td>3.61</td>
<td>2</td>
<td>3.17</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>4.08</td>
<td>3.58</td>
<td>2.65</td>
<td>3.73</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>1.0%</td>
<td>5.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1744725655_0_0.png" alt="eps graph" />
<h3>Tracking Progressive's Stock Performance</h3>
Shares of Progressive were trading at $278.56 as of April 14. Over the last 52-week period, shares are up 33.66%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/PGR/earnings">To track all earnings releases for Progressive visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Progressive's Earnings Outlook

During the last three months, 4 analysts shared their evaluations of SM Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SM#NYSE">SM</a>), revealing diverse outlooks from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $42.25, a high estimate of $55.00, and a low estimate of $33.00. This current average has decreased by 23.18% from the previous average price target of $55.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1744725650_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of SM Energy among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Mike Scialla &#x7C;Stephens &amp; Co. &#x7C;Lowers &#x7C;Overweight &#x7C; $55.00&#x7C;$62.00 &#x7C; 
&#x7C;Hanwen Chang &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $33.00&#x7C;$45.00 &#x7C; 
&#x7C;Zach Parham &#x7C;JP Morgan &#x7C;Lowers &#x7C;Neutral &#x7C; $41.00&#x7C;$54.00 &#x7C; 
&#x7C;John Freeman &#x7C;Raymond James &#x7C;Lowers &#x7C;Outperform &#x7C; $40.00&#x7C;$59.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to SM Energy. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of SM Energy compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of SM Energy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of SM Energy's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/SM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on SM Energy analyst ratings.</a>
<h2>About SM Energy</h2>
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.
<h3>Unraveling the Financial Story of SM Energy</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: SM Energy's remarkable performance in 3M is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 37.74%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Energy sector.
Net Margin: SM Energy's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 22.53%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 4.54%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): SM Energy's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.27% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 0.66, SM Energy faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where SM Energy Stands With Analysts

Investors with a lot of money to spend have taken a bullish stance on CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CRWD, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 11 uncommon options trades for CrowdStrike Holdings.
This isn't normal.
The overall sentiment of these big-money traders is split between 63% bullish and 9%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $122,588, and 7 are calls, for a total amount of $896,371.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $220.0 to $450.0 for CrowdStrike Holdings over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for CrowdStrike Holdings's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of CrowdStrike Holdings's whale trades within a strike price range from $220.0 to $450.0 in the last 30 days. 
<h3>CrowdStrike Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744725649_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$115.0</td>
<td>$114.55</td>
<td>$115.0</td>
<td>$360.00</td>
<td>$575.0K</td>
<td>298</td>
<td align="right">50</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$122.4</td>
<td>$117.25</td>
<td>$122.4</td>
<td>$300.00</td>
<td>$110.1K</td>
<td>1.1K</td>
<td align="right">9</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$79.6</td>
<td>$75.45</td>
<td>$77.05</td>
<td>$330.00</td>
<td>$77.0K</td>
<td>83</td>
<td align="right">10</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$96.5</td>
<td>$92.25</td>
<td>$94.38</td>
<td>$340.00</td>
<td>$47.1K</td>
<td>461</td>
<td align="right">6</td>
</tr>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$41.45</td>
<td>$39.8</td>
<td>$39.8</td>
<td>$400.00</td>
<td>$35.8K</td>
<td>562</td>
<td align="right">9</td>
</tr>
</tbody>
</table>

<h3>About CrowdStrike Holdings</h3>
CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.
Following our analysis of the options activities associated with CrowdStrike Holdings, we pivot to a closer look at the company's own performance.
<h3>Where Is CrowdStrike Holdings Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 233,996, with CRWD's price up by 2.05%, positioned at $386.41.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 49 days.</li>
</ul>
<h3>Professional Analyst Ratings for CrowdStrike Holdings</h3>
Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $435.25.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on CrowdStrike Holdings with a target price of $410. 
&#x2A; Showing optimism, an analyst from BTIG upgrades its rating to Buy with a revised price target of $431. 
&#x2A; An analyst from Truist Securities persists with their Buy rating on CrowdStrike Holdings, maintaining a target price of $450. 
&#x2A; An analyst from Stephens &amp; Co. downgraded its action to Overweight with a price target of $450. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for CrowdStrike Holdings, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

CRWD

Smart Money Is Betting Big In CRWD Options

ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) is preparing to release its quarterly earnings on Wednesday, 2025-04-16. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect ASML Holding to report an earnings per share (EPS) of $5.76.
Anticipation surrounds ASML Holding's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.60, leading to a 3.42% increase in the share price the following trading session.
Here's a look at ASML Holding's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>6.71</td>
<td>5.42</td>
<td>4.05</td>
<td>3.430</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>7.31</td>
<td>5.80</td>
<td>4.32</td>
<td>3.377</td>
</tr>
<tr>
<td>Price Change %</td>
<td>3.0%</td>
<td>-6.0%</td>
<td>-1.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1744725643_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of ASML Holding were trading at $672.87 as of April 14. Over the last 52-week period, shares are down 24.78%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<h3>Analyst Views on ASML Holding</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on ASML Holding.
Analysts have provided ASML Holding with 1 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $1100.0, suggesting a potential 63.48% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of Applied Mat, KLA and Lam Research, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Applied Mat, with an average 1-year price target of $197.44, suggesting a potential 70.66% downside.</li>
<li>Analysts currently favor an Neutral trajectory for KLA, with an average 1-year price target of $790.13, suggesting a potential 17.43% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Lam Research, with an average 1-year price target of $95.0, suggesting a potential 85.88% downside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
Within the peer analysis summary, vital metrics for Applied Mat, KLA and Lam Research are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>ASML Holding</td>
<td>Outperform</td>
<td>27.99%</td>
<td>$4.79B</td>
<td>15.56%</td>
</tr>
<tr>
<td>Applied Mat</td>
<td>Buy</td>
<td>6.84%</td>
<td>$3.50B</td>
<td>6.30%</td>
</tr>
<tr>
<td>KLA</td>
<td>Neutral</td>
<td>23.73%</td>
<td>$1.86B</td>
<td>23.08%</td>
</tr>
<tr>
<td>Lam Research</td>
<td>Outperform</td>
<td>16.44%</td>
<td>$2.07B</td>
<td>13.79%</td>
</tr>
</tbody>
</table>

Key Takeaway:
ASML Holding ranks highest in Revenue Growth and Gross Profit among its peers. It also has the highest Return on Equity. Overall, ASML Holding outperforms its peers in key financial metrics.
<h3>Unveiling the Story Behind ASML Holding</h3>
ASML is the leader in photolithography systems used in manufacturing semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML's main clients are TSMC, Samsung, and Intel.
<h3>ASML Holding: A Financial Overview</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: ASML Holding's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 27.99%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: ASML Holding's net margin excels beyond industry benchmarks, reaching 29.08%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): ASML Holding's ROE excels beyond industry benchmarks, reaching 15.56%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): ASML Holding's ROA excels beyond industry benchmarks, reaching 5.96%. This signifies efficient management of assets and strong financial health.
Debt Management: ASML Holding's debt-to-equity ratio is below the industry average at 0.25, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/ASML/earnings">To track all earnings releases for ASML Holding visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASML

Earnings Outlook For ASML Holding

During the last three months, 5 analysts shared their evaluations of Bunge Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>), revealing diverse outlooks from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $83.6, a high estimate of $95.00, and a low estimate of $74.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 13.1%. 
<img src="https://www.benzinga.com/files/images/story/2025/1744725642_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A clear picture of Bunge Global's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Thomas Palmer &#x7C;Citigroup &#x7C;Raises &#x7C;Neutral &#x7C; $77.00&#x7C;$76.00 &#x7C; 
&#x7C;Vincent Andrews &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $74.00&#x7C;$90.00 &#x7C; 
&#x7C;Steve Byrne &#x7C;B of A Securities &#x7C;Lowers &#x7C;Buy &#x7C; $87.00&#x7C;$105.00 &#x7C; 
&#x7C;Benjamin Theurer &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $85.00&#x7C;$95.00 &#x7C; 
&#x7C;Benjamin Theurer &#x7C;Barclays &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $95.00&#x7C;$115.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Bunge Global. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Bunge Global compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Bunge Global's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Bunge Global's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Bunge Global analyst ratings.</a>
<h2>Delving into Bunge Global's Background</h2>
Bunge Global SA formerly Bunge Ltd is an agribusiness and food company with operations along the farm-to-consumer food chain. The company segments include Agribusiness; Refined and Specialty Oils; Milling; Sugar and Bioenergy and Corporate and Other. It generates maximum revenue from the Agribusiness segment. The company is an oilseed processor and producer of vegetable oils and protein meals, based on processing capacity, a grain processor, the seller of packaged plant-based oils, producer and seller of wheat flour, bakery mixes and corn-based products in North and South America.
<h3>Key Indicators: Bunge Global's Financial Health</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Challenges: Bunge Global's revenue growth over 3M faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -9.33%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: Bunge Global's net margin is impressive, surpassing industry averages. With a net margin of 4.45%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Bunge Global's ROE stands out, surpassing industry averages. With an impressive ROE of 6.01%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Bunge Global's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.4%, the company showcases efficient use of assets and strong financial health.
Debt Management: Bunge Global's debt-to-equity ratio stands notably higher than the industry average, reaching 0.72. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Bunge Global: Insights From 5 Financial Analysts

During the last three months, 4 analysts shared their evaluations of Darling Ingredients (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAR#NYSE">DAR</a>), revealing diverse outlooks from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Darling Ingredients and provided 12-month price targets. The average target is $45.25, accompanied by a high estimate of $52.00 and a low estimate of $41.00. Observing a downward trend, the current average is 4.39% lower than the prior average price target of $47.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1744725634_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of Darling Ingredients by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Thomas Palmer &#x7C;Citigroup &#x7C;Lowers &#x7C;Buy &#x7C; $44.00&#x7C;$45.00 &#x7C; 
&#x7C;Ben Kallo &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $41.00&#x7C;$51.00 &#x7C; 
&#x7C;Thomas Palmer &#x7C;Citigroup &#x7C;Lowers &#x7C;Buy &#x7C; $44.00&#x7C;$46.00 &#x7C; 
&#x7C;Pooran Sharma &#x7C;Stephens &amp; Co. &#x7C;Announces &#x7C;Overweight &#x7C; $52.00&#x7C;- &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Darling Ingredients. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Darling Ingredients compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Darling Ingredients's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Darling Ingredients's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DAR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Darling Ingredients analyst ratings.</a>
<h2>Delving into Darling Ingredients's Background</h2>
Darling Ingredients Inc develops and manufactures sustainable ingredients for customers in the pharmaceutical, food, pet food, fuel, and fertilizer industries. It collects and transforms all aspects of animal by-product streams into ingredients, including gelatin, fats, proteins, pet food ingredients, fertilizers. Also, the company recovers and converts used cooking oil and bakery remnants into feed and fuel ingredients. Darling has three primary business segments which are feed ingredients contributing the majority of revenue, food ingredients, and fuel ingredients. It provides grease trap services for food businesses and sells various equipment for collecting and delivering cooking oil. The company derives the majority of its revenue from customers in North America.
<h3>Darling Ingredients's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Decline in Revenue: Over the 3M period, Darling Ingredients faced challenges, resulting in a decline of approximately -12.17% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Darling Ingredients's net margin excels beyond industry benchmarks, reaching 7.19%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.28%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Darling Ingredients's ROA excels beyond industry benchmarks, reaching 0.99%. This signifies efficient management of assets and strong financial health.
Debt Management: Darling Ingredients's debt-to-equity ratio stands notably higher than the industry average, reaching 0.97. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Darling Ingredients: Insights From 4 Analyst Reviews

JD.com's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JD#NYSE">JD</a>) short percent of float has fallen 18.98% since its last report. The company recently reported that it has 22.64 million shares sold short, which is 1.75% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.21 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>JD.com Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744725633_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for JD.com has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing JD.com's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, JD.com's peer group average for short interest as a percentage of float is 10.21%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

What Does the Market Think About JD.com?

Prologis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLD#NYSE">PLD</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-04-16. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Prologis will report an earnings per share (EPS) of $1.38.
Prologis bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.12, leading to a 1.82% drop in the share price the following trading session.
Here's a look at Prologis's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.38</td>
<td>1.38</td>
<td>1.33</td>
<td>1.28</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.50</td>
<td>1.43</td>
<td>1.34</td>
<td>1.28</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>-3.0%</td>
<td>-0.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1744725632_0.png" alt="eps graph" />
<h3>Tracking Prologis's Stock Performance</h3>
Shares of Prologis were trading at $98.3 as of April 14. Over the last 52-week period, shares are down 7.19%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analyst Observations about Prologis</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Prologis.
With 5 analyst ratings, Prologis has a consensus rating of Buy. The average one-year price target is $123.67, indicating a potential 25.81% upside.
<h3>Analyzing Ratings Among Peers</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Lineage, EastGroup Properties and Rexford Industrial Realty, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Lineage, with an average 1-year price target of $69.7, suggesting a potential 29.09% downside.</li>
<li>Analysts currently favor an Neutral trajectory for EastGroup Properties, with an average 1-year price target of $181.0, suggesting a potential 84.13% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Rexford Industrial Realty, with an average 1-year price target of $43.0, suggesting a potential 56.26% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
In the peer analysis summary, key metrics for Lineage, EastGroup Properties and Rexford Industrial Realty are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Prologis</td>
<td>Buy</td>
<td>16.48%</td>
<td>$1.68B</td>
<td>2.39%</td>
</tr>
<tr>
<td>Lineage</td>
<td>Outperform</td>
<td>0.37%</td>
<td>$433M</td>
<td>-0.80%</td>
</tr>
<tr>
<td>EastGroup Properties</td>
<td>Neutral</td>
<td>9.99%</td>
<td>$120.85M</td>
<td>1.91%</td>
</tr>
<tr>
<td>Rexford Industrial Realty</td>
<td>Neutral</td>
<td>15.43%</td>
<td>$186.89M</td>
<td>0.74%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Prologis ranks at the top for Revenue Growth and Gross Profit among its peers. It is in the middle for Consensus rating and Return on Equity.
<h3>Get to Know Prologis Better</h3>
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1.2 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $60 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
<h3>Financial Insights: Prologis</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Over the 3 months period, Prologis showcased positive performance, achieving a revenue growth rate of 16.48% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 58.05%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Prologis's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.39%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Prologis's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.34%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.58, Prologis adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/PLD/earnings">To track all earnings releases for Prologis visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Preview: Prologis's Earnings

Elevance Health's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) short percent of float has risen 9.01% since its last report. The company recently reported that it has 2.75 million shares sold short, which is 1.21% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.82 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Elevance Health Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744725627_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Elevance Health has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Elevance Health's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Elevance Health's peer group average for short interest as a percentage of float is 4.67%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

How Do Investors Really Feel About Elevance Health?

In the current market session, Trinity Indus Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRN#NYSE">TRN</a>) price is at $25.43, after a 0.67% increase. However, over the past month, the stock fell by 12.66%, and in the past year, by 1.66%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1744725626_0.png" alt="Past Year Chart" />

<h3>Trinity Indus P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 24.49 in the Machinery industry, Trinity Indus Inc. has a lower P/E ratio of 14.12. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1744725626_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

A Look Into Trinity Indus Inc's Price Over Earnings

21 analysts have expressed a variety of opinions on Klaviyo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVYO#NYSE">KVYO</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">7</td>
<td align="right">9</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">7</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $50.05, along with a high estimate of $56.00 and a low estimate of $40.00. Surpassing the previous average price target of $46.11, the current average has increased by 8.54%.
<img src="https://www.benzinga.com/files/images/story/2025/1744725624_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Klaviyo among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Siti Panigrahi &#x7C;Mizuho &#x7C;Lowers &#x7C;Outperform &#x7C; $40.00&#x7C;$52.00 &#x7C; 
&#x7C;Brett Huff &#x7C;Stephens &amp; Co. &#x7C;Announces &#x7C;Overweight &#x7C; $43.00&#x7C;- &#x7C; 
&#x7C;Brett Huff &#x7C;Stephens &amp; Co. &#x7C;Announces &#x7C;Overweight &#x7C; $43.00&#x7C;- &#x7C; 
&#x7C;Scott Berg &#x7C;Needham &#x7C;Maintains &#x7C;Buy &#x7C; $56.00&#x7C;$56.00 &#x7C; 
&#x7C;Brent Bracelin &#x7C;Piper Sandler &#x7C;Maintains &#x7C;Overweight &#x7C; $53.00&#x7C;$53.00 &#x7C; 
&#x7C;Parker Lane &#x7C;Stifel &#x7C;Raises &#x7C;Buy &#x7C; $54.00&#x7C;$45.00 &#x7C; 
&#x7C;Raimo Lenschow &#x7C;Barclays &#x7C;Raises &#x7C;Overweight &#x7C; $51.00&#x7C;$47.00 &#x7C; 
&#x7C;Gabriela Borges &#x7C;Goldman Sachs &#x7C;Raises &#x7C;Buy &#x7C; $51.00&#x7C;$45.00 &#x7C; 
&#x7C;Siti Panigrahi &#x7C;Mizuho &#x7C;Raises &#x7C;Outperform &#x7C; $52.00&#x7C;$42.00 &#x7C; 
&#x7C;David Hynes &#x7C;Canaccord Genuity &#x7C;Raises &#x7C;Buy &#x7C; $50.00&#x7C;$40.00 &#x7C; 
&#x7C;Elizabeth Porter &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Equal-Weight &#x7C; $50.00&#x7C;$47.00 &#x7C; 
&#x7C;Brett Knoblauch &#x7C;Cantor Fitzgerald &#x7C;Raises &#x7C;Overweight &#x7C; $54.00&#x7C;$47.00 &#x7C; 
&#x7C;Rob Oliver &#x7C;Baird &#x7C;Raises &#x7C;Outperform &#x7C; $54.00&#x7C;$52.00 &#x7C; 
&#x7C;Mark Zgutowicz &#x7C;Benchmark &#x7C;Raises &#x7C;Buy &#x7C; $54.00&#x7C;$51.00 &#x7C; 
&#x7C;Michael Berg &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $45.00&#x7C;$48.00 &#x7C; 
&#x7C;Brent Bracelin &#x7C;Piper Sandler &#x7C;Raises &#x7C;Overweight &#x7C; $53.00&#x7C;$50.00 &#x7C; 
&#x7C;Scott Berg &#x7C;Needham &#x7C;Raises &#x7C;Buy &#x7C; $56.00&#x7C;$46.00 &#x7C; 
&#x7C;Mark Zgutowicz &#x7C;Benchmark &#x7C;Raises &#x7C;Buy &#x7C; $51.00&#x7C;$40.00 &#x7C; 
&#x7C;Michael Berg &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $48.00&#x7C;$41.00 &#x7C; 
&#x7C;Tyler Radke &#x7C;Citigroup &#x7C;Raises &#x7C;Neutral &#x7C; $48.00&#x7C;$39.00 &#x7C; 
&#x7C;Nick Altmann &#x7C;Scotiabank &#x7C;Raises &#x7C;Sector Perform &#x7C; $45.00&#x7C;$35.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Klaviyo. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Klaviyo compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Klaviyo's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Klaviyo's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/KVYO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Klaviyo analyst ratings.</a>
<h2>Delving into Klaviyo's Background</h2>
Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.
<h3>Klaviyo: Financial Performance Dissected</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Positive Revenue Trend: Examining Klaviyo's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 34.0% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: Klaviyo's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -9.98%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Klaviyo's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -2.63%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Klaviyo's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -2.19%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Klaviyo's debt-to-equity ratio is below the industry average at 0.05, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

KVYO

What Analysts Are Saying About Klaviyo Stock

Intuitive Machines's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NYSE">LUNR</a>) short percent of float has fallen 12.86% since its last report. The company recently reported that it has 18.79 million shares sold short, which is 17.69% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.57 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Intuitive Machines Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744725621_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Intuitive Machines has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Intuitive Machines's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Intuitive Machines's peer group average for short interest as a percentage of float is 8.00%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

LUNR

Peering Into Intuitive Machines's Recent Short Interest

Goldman Sachs analyst Chao Ji downgrades Daqo New Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DQ#NYSE">DQ</a>) from Buy to Neutral.

Downgrades

Goldman Sachs Downgrades Daqo New Energy to Neutral

Dividends

Press Releases

IMPERIAL PETROLEUM INC. Declares Dividend on Series A Preferred Shares

Imperial Petroleum Inc. Announces the Date for the Release of Second Quarter and Six Months 2024

Imperial Petroleum Inc. Reports Second Quarter and Six Months 2024 Financial and Operating Results

Imperial Petroleum Inc. Announces the Date for the Release of Third Quarter and Nine Months 2024 Financial and Operating Results, Conference Call and Webcast

IMPERIAL PETROLEUM INC. Reports Third Quarter and Nine Months 2024 Financial and Operating Results

Imperial Petroleum Inc. Announces the Date for the Release of Fourth Quarter and Twelve Months 2024 Financial and Operating Results, Conference Call and Webcast

Imperial Petroleum Inc. Reports Fourth Quarter and Twelve Months 2024 Financial and Operating Results

Imperial Petroleum Inc. Declares Dividend on Series A Preferred Shares

IMPP

IMPPP

Ardmore Shipping Corporation Common Stock

Ardmore Shipping

CBL International Limited - Ordinary Shares

CBL International

Brooge Energy

Crown LNG Holdings Limited - Ordinary Shares

Crown LNG Holdings

Cool Co

Dynagas LNG Partners

StealthGas

KNOT Offshore Partners LP Common Units representing Limited Partner Interests

KNOT Offshore Partners

Martin Midstream Partners L.P. - Common Units Representing Limited Partnership Interests

Comments

Imperial Ptrl

Noticias

Últimas noticias sobre Imperial Ptrl (NASDAQ:IMPP) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL